Cargando…
Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development
Mutations in the exonuclease domain of POLE are associated with tumors harboring very high mutation burdens. The mechanisms linking this significant mutation accumulation and tumor development remain poorly understood. Pole(+/P286R);Trp53(+/–) mice showed accelerated cancer mortality compared to Pol...
Autores principales: | Park, Vivian S, Sun, Meijuan J S, Frey, Wesley D, Williams, Leonard G, Hodel, Karl P, Strauss, Juliet D, Wellens, Sydney J, Jackson, James G, Pursell, Zachary F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892059/ https://www.ncbi.nlm.nih.gov/pubmed/35252866 http://dx.doi.org/10.1093/narcan/zcac004 |
Ejemplares similares
-
The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity
por: Labrousse, Guillaume, et al.
Publicado: (2023) -
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma
por: Armstrong, Chris W D, et al.
Publicado: (2020) -
ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe
por: Heyza, Joshua R, et al.
Publicado: (2023) -
Dual inhibition of DNA-PK and DNA polymerase theta overcomes radiation resistance induced by p53 deficiency
por: Kumar, Rashmi J, et al.
Publicado: (2020) -
CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination
por: Brown, Victoria E, et al.
Publicado: (2023)